Halozyme Therapeutics reported $1.78B in Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
DBV Technologies DBVT:US 284.98M 167.4M
Acadia Pharmaceuticals ACAD:US $ 612.77M 11.48M
Agios Pharmaceuticals AGIO:US $ 1252.47M 83.39M
Alnylam Pharmaceuticals ALNY:US $ 3330.42M 103.13M
Amarin AMRN:US $ 973.24M 0.47M
Amgen AMGN:US $ 59294M 98M
Aptinyx Inc APTX:US $ 92.31M 14.35M
Baxter International BAX:US $ 31831M 885M
Cara Therapeutics CARA:US $ 226.57M 2.71M
Cytokinetics CYTK:US $ 771.72M 84.54M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Esperion Therapeutics ESPR:US $ 303.98M 38.87M
Halozyme Therapeutics HALO:US $ 1781.39M 619.14M
Immunogen IMGN:US $ 422.3M 59.41M
Intercept Pharmaceuticals ICPT:US $ 498.6M 4.76M
Intra Cellular Therapies ITCI:US $ 811.91M 56.67M
Intrexon XON:US $ 321.22M 14.34M
JAZZ PHA JAZZ:US $ 11200.13M 568.78M
Mannkind MNKD:US $ 285.8M 22.52M
Minerva Neurosciences NERV:US $ 64.96M 5.66M
Nektar Therapeutics NKTR:US $ 861.99M 162.13M
Peregrine Pharmaceuticals PPHM:US $ 451.22M 21.38M
United Therapeutics UTHR:US $ 5543.3M 183.5M
Vanda Pharmaceuticals VNDA:US $ 609.1M 5.54M